Press Releases
Site - Investor Relations
Predictive Oncology Sends Letter to Shareholders Regarding Special Meeting to be Reconvened on December 30, 2020
The Board of Directors and management of
The full text of the letter follows:
Dear Shareholder,
Our Special Meeting of the Shareholders on
We previously sent you proxy materials in connection with our Special Meeting of Shareholders, and according to our records, we have not yet received your vote.
We are asking you to vote for allowing the Company to reincorporate in the state of
Your vote is very important, regardless of the number of shares you own.
The reincorporation, to be approved at the Special Meeting, must receive a “For” vote from a majority of the outstanding shares of common stock of the Company. At our recent Annual Meeting, the Reincorporation vote received far more “For” votes than “Against” votes, however, we did not reach the required number of total votes for a majority of the outstanding shares.
Please take a moment to vote your shares by following the instructions in your proxy materials. You may vote online or by telephone.
Please disregard this letter if you have already voted your shares for the reincorporation.
If you have any concerns please contact either
Thank you for your cooperation and support.
Sincerely,
Chief Executive Officer
About
Forward-Looking Statements
Certain matters discussed in this release contain forward-looking statements. These forward-looking statements reflect our current expectations and projections about future events and are subject to substantial risks, uncertainties and assumptions about our operations and the investments we make. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial position, future revenue and financial performance, projected costs, prospects, plans and objectives of management are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “would,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our actual future performance may materially differ from that contemplated by the forward-looking statements as a result of a variety of factors including, among other things, factors discussed under the heading “Risk Factors” in our filings with the
Investor Relations Contact:
Hayden IR
James Carbonara
(646)-755-7412
Source: Predictive Oncology Inc.